Genomics

Dataset Information

0

Allogeneic antibodies specifically target AML antigen NuSAP1 after bone marrow transplantation


ABSTRACT: Identifying the targets of immune response after allogeneic hematopoietic cell transplantation (HCT) promises to provide relevant immune therapy candidate proteins. We used protein microarrays to serologically identify Nucleolar and Spindle Associated Protein 1 (NuSAP1) and Chromatin Assembly Factor 1, subunit B (p60) [CHAF1b] as targets of new antibody responses that developed after allogeneic HCT. Western blots and ELISA validated their post-HCT recognition and enabled ELISA testing of 120 other allo-HCT patients. CHAF1b specific antibodies were predominantly detected in AML patients whereas NuSAP1 specific antibodies were exclusively detected in AML patients one year post-transplant (p<0.0001). Complete genomic exon sequencing failed to identify a nonsynonymous SNP for NuSAP1 and CHAF1b between the donor and recipient cells. Expression profiles and RT-PCR showed NuSAP1 was predominately expressed in the bone marrow CD34+CD90+ hematopoietic stem cells (HSC), leukemic cell lines and B lymphoblasts as compared to other tissues or cells. Thus, NuSAP1 is recognized as an immunogenic antigen in 65% AML patients and suggests a tumor antigen role. In conclusion, clinically important tumor antigens can be identified as new antibody targets after allogeneic HCT using high density protein microarrays

ORGANISM(S): Homo sapiens

PROVIDER: GSE15255 | GEO | 2009/03/19

SECONDARY ACCESSION(S): PRJNA116549

REPOSITORIES: GEO

Similar Datasets

| E-GEOD-15255 | biostudies-arrayexpress
| PRJNA116549 | ENA
2022-03-11 | GSE198141 | GEO
2017-12-19 | GSE95770 | GEO
2022-09-20 | GSE158103 | GEO
2023-06-01 | GSE231512 | GEO
2023-05-02 | GSE161343 | GEO
| E-GEOD-64300 | biostudies-arrayexpress
2023-06-26 | GSE207104 | GEO
| E-GEOD-23924 | biostudies-arrayexpress